Many reports have shown that IL-33 is highly expressed in a variety of chronic inflammatory conditions, such as chronic hepatitis B, liver fibrosis, and precancerous lesions, suggesting that IL-33 may play an important role in the progression of inflammation to tumors [2–6]. This evidence concerns the gene IL33 and Hepatic fibrosis.